Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2005 Feb;54(2):268-73.
doi: 10.1136/gut.2004.044214.

Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery

L Ciccolallo  1 , R Capocaccia, M P Coleman, F Berrino, J W W Coebergh, R A M Damhuis, J Faivre, C Martinez-Garcia, H Møller, M Ponz de Leon, G Launoy, N Raverdy, E M I Williams, G Gatta
Affiliations
Multicenter Study

Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery

L Ciccolallo et al. Gut. 2005 Feb.

Abstract

Background: Population based colorectal cancer survival among patients diagnosed in 1985-89 was lower in Europe than in the USA (45% v 59% five year relative survival).

Aims: To explain this difference in survival using a new analytic approach for patients diagnosed between 1990 and 1991.

Subjects: A total of 2492 European and 11 191 US colorectal adenocarcinoma patients registered by 10 European and nine US cancer registries.

Methods: We obtained clinical information on disease stage, number of lymph nodes examined, and surgical treatment. We analysed three year relative survival, calculating relative excess risks of death (RERs, referent category US patients) adjusted for age, sex, site, surgery, stage, and number of nodes examined, using a new multivariable approach.

Results: We found that 85% of European patients and 92% of US patients underwent surgical resection. Three year relative survival was 69% for US patients and 57% for European patients. After adjustment for age, sex, and site, the RER was significantly high in all 10 European populations, ranging from 1.07 (95% confidence interval 0.86-1.32) (Modena, Italy) to 2.22 (1.79-2.76) (Thames, UK). After further adjustment for stage, surgical resection, and number of nodes examined (a determinant of stage), RERs ranged from 0.77 (0.62-0.96) to 1.59 (1.28-1.97). For some European registries the excess risk was small and not statistically significant.

Conclusions: US-Europe survival differences in colorectal cancer are large but seem to be mostly attributable to differences in stage at diagnosis. There are wide variations in diagnostic and surgical practice between Europe and the USA.

PubMed Disclaimer

References

    1. Gatta G , Capocaccia R, Coleman MP, et al. Toward a comparison of survival in American and European cancer patients. Cancer 2000;89:893–900. - PubMed
    1. Gatta G , Capocaccia R, Sant M, et al. Understanding variation in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000;47:533–8. - PMC - PubMed
    1. Gatta G , Ciccolallo L, Capocaccia R, the EUROCARE Working Group, et al. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer October2003;39:2214–22. - PubMed
    1. Berrino F , Estève J, Coleman MP. Basic issues in estimating and comparing the survival of cancer patients. In: Berrino F, Sant M, Verdecchia A, et al, eds. Survival of cancer patients in Europe. The Eurocare Study. IARC Scient Publ No 132. Lyon: International Agency for Research on Cancer, 1995:1–14. - PubMed
    1. Sant M , the EUROCARE Working Group. Differences in stage and therapy for breast cancer across Europe. Int J Cancer 2001;93:894–901. - PubMed

Publication types